ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,856Medicare Part D Prescriptions Filled, Including Refills
$691K Total Retail Price of All Prescriptions
175 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
NAMENDA 341 341
PRENATAL PLUS 279 257 10
LISINOPRIL 255 204
WARFARIN SODIUM 251 242
LANTUS 217 175
DONEPEZIL HCL 208 208
METOPROLOL TARTRATE 196 184
HYDROCODONE-ACETAMINOPHEN 196 183 S3
AMLODIPINE BESYLATE 193 147
OMEPRAZOLE 179 167
FUROSEMIDE 155 154
CARVEDILOL 147 94
LEVOTHYROXINE SODIUM 143 143
SIMVASTATIN 140 126
POTASSIUM CHLORIDE 137 126
METFORMIN HCL 137 100
GABAPENTIN 129 115
LACTULOSE 129 108
TRAZODONE HCL 121 95
NEXIUM 121 109
HYDROCHLOROTHIAZIDE 117 104
PRAVASTATIN SODIUM 114 114
NOVOLIN R 110 99
SANTYL 108 108
MIRTAZAPINE 104 85
METOCLOPRAMIDE HCL 99 88
ENALAPRIL MALEATE 91 74
ESCITALOPRAM OXALATE 90 79
SPIRIVA 88 78
ADVAIR DISKUS 87 77
ISOSORBIDE MONONITRATE ER 86 78
POLYETHYLENE GLYCOL 3350 84 83
OLANZAPINE 81 59
ALLOPURINOL 80 56
LOSARTAN POTASSIUM 75 63
DIOVAN 75 75
LEXAPRO 74 66
DIGOXIN 70 42
GLIMEPIRIDE 69 47
CYMBALTA 69 51
CARBIDOPA-LEVODOPA 65 65
RISPERIDONE 62 62
CITALOPRAM HBR 62 58
FLUTICASONE PROPIONATE 61 61
CLOPIDOGREL 58 57
DETROL LA 57 44
HUMULIN R 57 42
CLONIDINE HCL 56 56
LEVOTHROID 55 55
METOPROLOL SUCCINATE 54 42
FINASTERIDE 52 47
KETOCONAZOLE 50 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.